Avidian Wealth Enterprises LLC Has $549,000 Holdings in Intuitive Surgical, Inc. $ISRG

Avidian Wealth Enterprises LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,010 shares of the medical equipment provider’s stock after purchasing an additional 22 shares during the period. Avidian Wealth Enterprises LLC’s holdings in Intuitive Surgical were worth $549,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Chilton Capital Management LLC increased its position in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. TD Capital Management LLC increased its holdings in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 13.9%

Shares of NASDAQ:ISRG opened at $527.03 on Thursday. The business has a 50 day moving average price of $455.28 and a 200 day moving average price of $495.80. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market cap of $188.93 billion, a price-to-earnings ratio of 69.71, a PEG ratio of 4.86 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.03% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the company earned $1.84 EPS. The firm’s revenue for the quarter was up 22.9% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. BTIG Research increased their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday. Piper Sandler increased their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday. The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday, October 1st. Finally, Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $599.68.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.